GSK Thalidomide Suit To Stay In Fed. Court: 3rd Circ.

A Third Circuit panel on Friday affirmed a district court holding keeping a suit over GlaxoSmithKline LLC's morning-sickness drug thalidomide in federal court, finding that a 10-foot-by-10-foot office in Wilmington, Del.,...

Already a subscriber? Click here to view full article